analyst
NASDAQ · BMRN
BioMarin Pharmaceutical Inc.
Healthcare · Biotechnology
$64.45
Up+$0.34 (+0.52%)
Updated Sep 16, 2026, 2:52 PM
SID Score
6.5/10
Composite research score
Smart Money
54/100
Neutral
- Market cap
- 10.18B
- P/E ratio
- 19.56
- Dividend yield
- 0.00%
- 52-week range
- $49.26 – $70.98
- Volume
- 1.85M
- Avg. volume
- 2.67M
Price performance
BMRN price history
1M range · 20 trading sessions · Daily adjusted prices
BMRN closed at $64.45 after 20 trading sessions, down 3.79% for the selected period.
- Last close
- $64.45
- Period change
- -3.79%
- Period low
- $64.41
- Period high
- $69.33
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $65.78 | $65.78 | $63.85 | $64.45 | 1.85M |
| Sep 14, 2026 | $66.27 | $66.88 | $65.72 | $66.41 | 1.34M |
| Sep 11, 2026 | $65.96 | $66.05 | $65.285 | $65.68 | 1.6M |
| Sep 10, 2026 | $64.41 | $65.59 | $63.5742 | $65.51 | 2.2M |
| Sep 9, 2026 | $63.83 | $65.325 | $63.64 | $64.41 | 1.95M |
| Sep 8, 2026 | $65.24 | $66.26 | $64.01 | $64.63 | 1.46M |
| Sep 4, 2026 | $65.785 | $66.64 | $65.52 | $66.53 | 2.3M |
| Sep 3, 2026 | $67.30 | $67.695 | $66.32 | $66.43 | 1.48M |
| Sep 2, 2026 | $65.00 | $67.20 | $64.99 | $66.97 | 2.52M |
| Sep 1, 2026 | $65.54 | $66.015 | $64.49 | $64.84 | 1.78M |
| Aug 31, 2026 | $65.95 | $66.2972 | $64.33 | $65.23 | 2.3M |
| Aug 28, 2026 | $64.99 | $65.08 | $64.07 | $64.665 | 1.1M |
| Aug 27, 2026 | $65.28 | $65.915 | $64.83 | $65.29 | 1.25M |
| Aug 26, 2026 | $65.62 | $66.5322 | $65.33 | $65.61 | 1.88M |
| Aug 25, 2026 | $65.03 | $66.36 | $65.02 | $66.12 | 1.36M |
| Aug 24, 2026 | $66.57 | $67.18 | $64.71 | $65.07 | 2.26M |
| Aug 21, 2026 | $67.55 | $68.34 | $66.52 | $66.70 | 1.59M |
| Aug 20, 2026 | $68.106 | $68.75 | $67.565 | $67.68 | 1.28M |
| Aug 19, 2026 | $68.17 | $69.62 | $67.75 | $69.33 | 1.98M |
| Aug 18, 2026 | $67.21 | $68.265 | $66.84 | $66.99 | 1.94M |
Latest BMRN news
The latest Smart Investors Daily articles mentioning BMRN.
Stock researchResearch & News · SEC Filings
Loading stock research…